State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Diseases Hospital, Center for Stem Cell Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Haematologica. 2019 Feb;104(2):245-255. doi: 10.3324/haematol.2018.194811. Epub 2018 Sep 27.
Hematopoietic stem cells constitute a unique subpopulation of blood cells that can give rise to all types of mature cells in response to physiological demands. However, the intrinsic molecular machinery that regulates this transformative property remains elusive. In this paper, we demonstrate that small GTPase Rheb1 is a critical regulator of proliferation and differentiation of hematopoietic stem cells Rheb1 deletion led to increased phenotypic hematopoietic stem cell/hematopoietic progenitor cell proliferation under a steady state condition. Over-proliferating Rheb1-deficient hematopoietic stem cells were severely impaired in functional repopulation assays, and they failed to regenerate the blood system when challenged with hematopoietic ablation by sublethal irradiation. In addition, it was discovered that Rheb1 loss resulted in a lack of maturation of neutrophils / caused neutrophil immaturation by reducing mTORC1 activity, and that activation of the mTORC1 signaling pathway by mTOR activator 3BDO partially restored the maturation of Rheb1-deficient neutrophils. Rheb1 deficiency led to a progressive enlargement of the hematopoietic stem cell population and an eventual excessive myeloproliferation , including an overproduction of peripheral neutrophils and an excessive expansion of extramedullary hematopoiesis. Moreover, low RHEB expression was correlated with poor survival in acute myeloid leukemia patients with normal karyotype. Our results, therefore, demonstrate a critical and unique role for Rheb1 in maintaining proper hematopoiesis and myeloid differentiation.
造血干细胞是血细胞中的一个独特亚群,能够响应生理需求产生所有类型的成熟细胞。然而,调节这种转化特性的内在分子机制仍然难以捉摸。在本文中,我们证明小 GTPase Rheb1 是造血干细胞增殖和分化的关键调节因子。Rheb1 缺失导致在稳态条件下造血干细胞/造血祖细胞增殖的表型增加。过度增殖的 Rheb1 缺陷造血干细胞在功能性重编程实验中严重受损,并且当受到亚致死辐射引起的造血细胞消融的挑战时,它们无法再生血液系统。此外,研究发现 Rheb1 缺失导致中性粒细胞成熟缺失/通过降低 mTORC1 活性导致中性粒细胞不成熟,并且通过 mTOR 激活剂 3BDO 激活 mTORC1 信号通路部分恢复了 Rheb1 缺陷中性粒细胞的成熟。Rheb1 缺失导致造血干细胞群体的逐渐扩大,最终导致过度的骨髓增生,包括外周中性粒细胞的过度产生和骨髓外造血的过度扩张。此外,低 RHEB 表达与正常核型急性髓系白血病患者的不良生存相关。因此,我们的研究结果表明 Rheb1 在维持适当的造血和髓样分化方面发挥着关键而独特的作用。